Patients Report Relief Of Ocular Symptoms After Xen Implantation – Michela Cimberle
The Xen45 gel stent can provide long-term IOP reduction in patients with refractory glaucoma, while offering a more favorable safety profile and relief from multiple ocular symptoms, according to a poster presented at the American Academy of Ophthalmology meeting in New Orleans. “The improvement in symptoms is likely related to reduced medication use,” said lead author of the poster, Joseph Panarelli, MD, assistant professor of ophthalmology at the Icahn School of Medicine at Mount Sinai, associate residency program director and glaucoma fellowship director at the New York Eye and Ear Infirmary of Mount Sinai. “We wanted to evaluate whether symptoms improved with the decrease or discontinuation of medication use and whether or not the surgery itself caused a worsening of symptoms.”
- Joseph Panarelli, MD, Assistant Professor, Ophthalmology, Icahn School of Medicine at Mount Sinai, Associate Residency Program Director, Glaucoma Fellowship Director, New York Eye and Ear Infirmary of Mount Sinai
Learn more